Eric L. Jenison, MD

McDowell Cancer Center at Akron ...Akron, Ohio - 44307 (330-344-6448) |
- CLINICAL TRIALS 10
- CONDITIONS7
- INTERVENTIONS25
- SINCE1992

Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
March 2005 - April 2008

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB Recurrent or Persistent Cervical Cancer
April 2009 - December 2011

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II Stage III or Stage IV Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer
August 2009 - January 2016

Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
December 2009 - December 2010

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy Paclitaxel and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
March 2009 - March 2013

Paclitaxel Carboplatin and Bevacizumab or Paclitaxel Carboplatin and Temsirolimus or Ixabepilone Carboplatin and Bevacizumab in Treating Patients With Stage III Stage IV or Recurrent Endometrial Cancer
October 2009 - July 2011

Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer
January 2010 - September 2013

Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer Primary Peritoneal Cavity Cancer or Fallopian Tube Cancer
December 2007 - December 2009

Collecting Tumor Samples From Patients With Gynecological Tumors
June 1992 -

Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer Primary Peritoneal Cavity Cancer or Fallopian Tube Cancer Undergoing Chemotherapy
September 2007 -
Ovarian Neoplasms
Fatigue
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Neurotoxicity Syndromes
Endometrial Neoplasms
Uterine Cervical Neoplasms
Intensity-Modulated Radiation Therapy
Laboratory Biomarker Analysis
Questionnaire Administration
Quality-Of-Life Assessment
Educational Intervention
Study Of Socioeconomic And Demographic Variables
Assessment Of Therapy Complications
Psychosocial Assessment And Care
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Radiation Therapy
Belinostat
Temsirolimus
Management Of Therapy Complications
Biologic Sample Preservation Procedure
Ixabepilone
Topotecan Hydrochloride
Clinical Observation
Brachytherapy
Internet-Based Intervention
Paclitaxel Poliglumex
Communication Intervention



